Cargando…

Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model

With favorable pharmacokinetics and binding affinity for α(v)β(3) integrin, (18)F-labeled dimeric cyclic RGD peptide ([(18)F]FPPRGD2) has been intensively used as a PET imaging probe for lesion detection and therapy response monitoring. A recently introduced kit formulation method, which uses an (18...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ning, Lang, Lixin, Li, Weihua, Kiesewetter, Dale O., Gao, Haokao, Niu, Gang, Xie, Qingguo, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356326/
https://www.ncbi.nlm.nih.gov/pubmed/22624041
http://dx.doi.org/10.1371/journal.pone.0037506
_version_ 1782233543169015808
author Guo, Ning
Lang, Lixin
Li, Weihua
Kiesewetter, Dale O.
Gao, Haokao
Niu, Gang
Xie, Qingguo
Chen, Xiaoyuan
author_facet Guo, Ning
Lang, Lixin
Li, Weihua
Kiesewetter, Dale O.
Gao, Haokao
Niu, Gang
Xie, Qingguo
Chen, Xiaoyuan
author_sort Guo, Ning
collection PubMed
description With favorable pharmacokinetics and binding affinity for α(v)β(3) integrin, (18)F-labeled dimeric cyclic RGD peptide ([(18)F]FPPRGD2) has been intensively used as a PET imaging probe for lesion detection and therapy response monitoring. A recently introduced kit formulation method, which uses an (18)F-fluoride-aluminum complex labeled RGD tracer ([(18)F]AlF-NOTA-PRGD2), provides a strategy for simplifying the labeling procedure to facilitate clinical translation. Meanwhile, an easy-to-prepare (68)Ga-labeled NOTA-PRGD2 has also been reported to have promising properties for imaging integrin α(v)β(3). The purpose of this study is to quantitatively compare the pharmacokinetic parameters of [(18)F]FPPRGD2, [(18)F]AlF-NOTA-PRGD2, and [(68)Ga]Ga-NOTA-PRGD2. U87MG tumor-bearing mice underwent 60-min dynamic PET scans following the injection of three tracers. Kinetic parameters were calculated using Logan graphical analysis with reference tissue. Parametric maps were generated using voxel-level modeling. All three compounds showed high binding potential (Bp(ND) = k(3)/k(4)) in tumor voxels. [(18)F]AlF-NOTA-PRGD2 showed comparable Bp(ND) value (3.75±0.65) with those of [(18)F]FPPRGD2 (3.39±0.84) and [(68)Ga]Ga-NOTA-PRGD2 (3.09±0.21) (p>0.05). Little difference was found in volume of distribution (V(T)) among these three RGD tracers in tumor, liver and muscle. Parametric maps showed similar kinetic parameters for all three tracers. We also demonstrated that the impact of non-specific binding could be eliminated in the kinetic analysis. Consequently, kinetic parameter estimation showed more comparable results among groups than static image analysis. In conclusion, [(18)F]AlF-NOTA-PRGD2 and [(68)Ga]Ga-NOTA-PRGD2 have comparable pharmacokinetics and quantitative parameters compared to those of [(18)F]FPPRGD2. Despite the apparent difference in tumor uptake (%ID/g determined from static images) and clearance pattern, the actual specific binding component extrapolated from kinetic modeling appears to be comparable for all three dimeric RGD tracers.
format Online
Article
Text
id pubmed-3356326
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33563262012-05-23 Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model Guo, Ning Lang, Lixin Li, Weihua Kiesewetter, Dale O. Gao, Haokao Niu, Gang Xie, Qingguo Chen, Xiaoyuan PLoS One Research Article With favorable pharmacokinetics and binding affinity for α(v)β(3) integrin, (18)F-labeled dimeric cyclic RGD peptide ([(18)F]FPPRGD2) has been intensively used as a PET imaging probe for lesion detection and therapy response monitoring. A recently introduced kit formulation method, which uses an (18)F-fluoride-aluminum complex labeled RGD tracer ([(18)F]AlF-NOTA-PRGD2), provides a strategy for simplifying the labeling procedure to facilitate clinical translation. Meanwhile, an easy-to-prepare (68)Ga-labeled NOTA-PRGD2 has also been reported to have promising properties for imaging integrin α(v)β(3). The purpose of this study is to quantitatively compare the pharmacokinetic parameters of [(18)F]FPPRGD2, [(18)F]AlF-NOTA-PRGD2, and [(68)Ga]Ga-NOTA-PRGD2. U87MG tumor-bearing mice underwent 60-min dynamic PET scans following the injection of three tracers. Kinetic parameters were calculated using Logan graphical analysis with reference tissue. Parametric maps were generated using voxel-level modeling. All three compounds showed high binding potential (Bp(ND) = k(3)/k(4)) in tumor voxels. [(18)F]AlF-NOTA-PRGD2 showed comparable Bp(ND) value (3.75±0.65) with those of [(18)F]FPPRGD2 (3.39±0.84) and [(68)Ga]Ga-NOTA-PRGD2 (3.09±0.21) (p>0.05). Little difference was found in volume of distribution (V(T)) among these three RGD tracers in tumor, liver and muscle. Parametric maps showed similar kinetic parameters for all three tracers. We also demonstrated that the impact of non-specific binding could be eliminated in the kinetic analysis. Consequently, kinetic parameter estimation showed more comparable results among groups than static image analysis. In conclusion, [(18)F]AlF-NOTA-PRGD2 and [(68)Ga]Ga-NOTA-PRGD2 have comparable pharmacokinetics and quantitative parameters compared to those of [(18)F]FPPRGD2. Despite the apparent difference in tumor uptake (%ID/g determined from static images) and clearance pattern, the actual specific binding component extrapolated from kinetic modeling appears to be comparable for all three dimeric RGD tracers. Public Library of Science 2012-05-18 /pmc/articles/PMC3356326/ /pubmed/22624041 http://dx.doi.org/10.1371/journal.pone.0037506 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Guo, Ning
Lang, Lixin
Li, Weihua
Kiesewetter, Dale O.
Gao, Haokao
Niu, Gang
Xie, Qingguo
Chen, Xiaoyuan
Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title_full Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title_fullStr Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title_full_unstemmed Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title_short Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
title_sort quantitative analysis and comparison study of [(18)f]alf-nota-prgd2, [(18)f]fpprgd2 and [(68)ga]ga-nota-prgd2 using a reference tissue model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356326/
https://www.ncbi.nlm.nih.gov/pubmed/22624041
http://dx.doi.org/10.1371/journal.pone.0037506
work_keys_str_mv AT guoning quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT langlixin quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT liweihua quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT kiesewetterdaleo quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT gaohaokao quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT niugang quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT xieqingguo quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel
AT chenxiaoyuan quantitativeanalysisandcomparisonstudyof18falfnotaprgd218ffpprgd2and68gaganotaprgd2usingareferencetissuemodel